A phase 3 randomised double-blind parallel group 24 week study to evaluate efficacy and sagety of once daily empagliflozin 10mg and 25mg compared to placebo all administed as oral fixed dose
- Simpson, Richard (Primary Chief Investigator (PCI))
Project: Research